The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: Evidence from preweanling rats

Psychopharmacology

Volumn 178, Issue 4, 2005, Pages 431-439

  McDougall, Sanders A ^a   Hernandez, Rita M ^a   Reichel, Carmela M ^a   Farley, Cristal M ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Amphetamine withdrawal; AMPT; NPA; Ontogeny; Partial D2 like receptor agonist; Terguride

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; METIROSINE; POSTSYNAPTIC RECEPTOR; PROPYLNORAPOMORPHINE; TERGURIDE; ALPHA-METHYLTYROSINE METHYL ESTER; APOMORPHINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; LISURIDE; METIROSINE METHYL ESTER; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; WEANING; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMPARATIVE STUDY; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HYPERKINESIA; METABOLISM; MOTOR ACTIVITY; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WITHDRAWAL SYNDROME;

ANIMALS; ANIMALS, NEWBORN; APOMORPHINE; BODY WEIGHT; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE ANTAGONISTS; HYPERKINESIS; LISURIDE; METHYLTYROSINES; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE 3-MONOOXYGENASE;

EID: 16844367469     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2033-1     Document Type: Article

References (50)

1. Arnt J (1983) Differential behavioural effects of dopamine agonists in developing rats: a study of 3-PPP enantiomers. Eur J Pharmacol 91:273-278
2. Arnt J, Hyttel J (1984) Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats. J Neural Transm 60:205-223
3. Arnt J, Hyttel J (1990) Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques. J Neural Transm 80:33-50
4. Barr AM, Phillips AG (1999) Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 141:99-106
5. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381-389
6. Callahan PM, Cunningham KA (1993) Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats. J Pharmacol Exp Ther 266:585-592
7. Carlsson A (1983) Dopamine receptor agonists: intrinsic activity vs state of the receptor. J Neural Transm 57:309-315
8. Clark D, Hjorth S, Carlsson A (1985a) Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. J Neural Transm 62:1-52
9. Clark D, Hjorth S, Carlsson A (1985b) Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J Neural Transm 62:171-207
10. Clark D, Furmidge LJ, Petry N, Tong Z-Y, Ericsson M, Johnson D (1991a) Behavioural profile of partial D2 dopamine receptor agonists. I. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy. Psychopharmacology (Berl) 105:381-392
11. Clark D, Salah RS, Galloway MP (1991b) Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine. Synapse 8:169-176
12. Di Lullo SL, Martin-Iverson MT (1991) Presynaptic dopaminergic neurotransmission mediates amphetamine-induced unconditioned but not amphetamine-conditioned locomotion and defecation in the rat. Brain Res 568:45-54
13. Drukarch B, Stoof JC (1990) D-2 dopamine autoreceptor selective drugs: do they really exist? Life Sci 47:361-376
14. Duke MA, O'Neal J, McDougall SA (1997) Ontogeny of dopamine agonist-induced sensitization: role of NMDA receptors. Psychopharmacology (Berl) 129:153-160
15. Exner M, Furmidge LJ, White FJ, Clark D (1989) Inhibitory effects of partial D2 dopamine receptor agonists on the d-amphetamine discriminative cue. Behav Pharmacol 1:101-111
16. Finn IB, Iuvone PM, Holtzman SG (1990) Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate. Neuropharmacology 29:625-631
17. Hoyer D, Boddeke HWGM (1993) Partial agonists, full agonists: dilemmas of definition. Trends Pharmacol Sci 14:270-275
18. Izzo E, Orsini C, Koob GF, Pulvirenti L (2001) A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule. Pharmacol Biochem Behav 68:701-708
19. Jung AB, Bennett JP Jr (1996) Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors. Dev Brain Res 94:109-120
20. Kehr W (1984) Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism. Eur J Pharmacol 97:111-119
21. Kenakin TP (1997) Pharmacological analysis of drug-receptor interactions. Lippincott Williams & Wilkins, Philadelphia
22. Kohler WC, Herbster G (1987) Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease. Neurology 37:723-727
23. Lal S, Sourkes TL (1973) Ontogeny of stereotyped behaviour induced by apomorphine and amphetamine in the rat. Arch Int Pharmacodyn 202:171-182
24. McDougall SA, Crawford CA, Nonneman AJ (1992) Effects of dopamine receptor inactivation on the locomotor activity and grooming of young and mature rats. Psychopharmacology (Berl) 106:502-510
25. 2 receptors. Psychopharmacology (Berl) 111:225-232
26. McDougall SA, Garmsen GM, Meier TL, Crawford CA (1997) Kappa opioid mediated locomotor activity hi the preweanling rat: role of pre and postsynaptic dopamine receptors. Psychopharmacology (Berl) 133:62-68
27. Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M (1987) Relationship between receptor occupancy and response at striatal autoreceptors. Mol Pharmacol 31:592-598
28. Meller E, Enz A, Goldstein M (1988) Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity. Eur J Pharmacol 155:151-154
29. Mestlin M, McDougall SA (1993) Ontogenetic differences in the effects of EEDQ on dopamine mediated behaviors. Pharmacol Biochem Behav 45:797-802
30. Moody CA, Spear LP (1992) Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weanling age period. Psychopharmacology (Berl) 106:161-168
31. Moody CA, Robinson SR, Spear LP, Smotherman WP (1993) Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations. Pharmacol Biochem Behav 44:843-850
32. 1 receptors in rat forebrain: a quantitative autoradiographic study. Dev Brain Res 57:7-13
33. 2-adrenoceptor. J Pharmacol Exp Their 303:805-814
34. Orsini C, Koob GF, Pulvirenti L (2001) Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 25:789-792
35. Pulvirenti L, Koob GF (1994) Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 15:374-379
36. Pulvirenti L, Balducci C, Piercy M, Koob GF (1998) Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. J Pharmacol Exp Ther 286:1231-1238
37. 2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Dev Brain Res 60:161-177
38. Ranaldi R, Wang Z, Woolverton WL (2001) Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys. Drug Alcohol Depend 64:209-217
39. Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221:227-234
40. 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62:65-85
41. Segal DS, Kuczenski R (1997) An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 17:2551-2566
42. 2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats. Pharmacol Biochem Behav 76:27-34
43. Sobrian SK, Weltman M, Pappas BA (1975) Neonatal locomotor and long-term behavioral effects of d-amphetamine in the rat. Dev Psychobiol 8:241-250
44. 2 partial agonists terguride, SDZ 208-911, and SDZ 208-912. Pharmacol Biochem Behav 51:661-665
45. Spear LP (1979) The use of psychopharmacological procedures to analyse the ontogeny of learning and retention: issues and concerns. In: Spear NE, Campbell BA (eds) Ontogeny of learning and memory. Lawrence Erlbaum Associates, Hillsdale, pp 135-156
46. Svensson K, Ekman A, Piercey MF, Hoffmann WE, Lum JT, Carlsson A (1991) Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study. Naunyn Schmiedebergs Arch Pharmacol 344:263-274
47. Tirelli E, Laviola G, Adriani W (2003) Ontogenesis of behavioral sensitization and conditioned place reference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev 27:163-178
48. Wachtel H, Dorow R (1983) Dual action on central dopamine function of transdihydrolisuride, a 9,10-dihydrogenated analogue of the ergot dopamine agonist lisuride. Life Sci 32:421-432
49. 3H]dopamine. Eur J Pharmacol 155:323-327
50. Zorrilla EP (1997) Multiparous species present problems (and possibilities) to developmentalists. Dev Psychobiol 30:141-150